文献速递血栓与止血

静脉血栓栓塞症诊断时D-二聚体水平低与复发风险降低相关:来自TROLL登记处的数据

Low D-dimer levels at diagnosis of venous thromboembolism are associated with reduced risk of recurrence: data from the TROLL registry.
PubMed 文献 · J Thromb Haemost · 2023-03-31

研究纳入TROLL登记处2585例首次症状性非癌症相关静脉血栓栓塞症患者(2005-2020年),按诊断时D-二聚体水平≤1900 ng/mL(≤第25百分位)与>1900 ng/mL分组,中位随访3.3年。结果示低D-二聚体组1年和5年累积复发率分别为2.9%和11.4%,高D-二聚体组分别为5.0%和18.3%。

要点

  • 诊断时D-二聚体≤1900 ng/mL组5年累积复发率为11.4%,>1900 ng/mL组为18.3%。
  • 无诱因VTE患者中,≤1900 ng/mL组5年累积复发率为14.3%,>1900 ng/mL组为20.2%。
  • 诊断时D-二聚体处于最低四分位与较低复发风险相关。

核心结论

  • 诊断时D-二聚体水平处于最低四分位与较低的静脉血栓栓塞症复发风险相关。
  • 作者认为诊断时测得的D-二聚体水平或可用于识别复发风险低的静脉血栓栓塞症患者。

研究设计与样本

  • 研究为基于静脉血栓登记处(TROLL)的队列研究,纳入2585例首次症状性非癌症相关静脉血栓栓塞症患者(2005-2020年)。
  • 按诊断时D-二聚体水平≤1900 ng/mL(≤第25百分位)与>1900 ng/mL分组,记录随访期间所有复发事件并估算累积复发率。

主要发现

  • 中位随访3.3年,共395例患者发生静脉血栓栓塞症复发。
  • D-二聚体≤1900 ng/mL组1年和5年累积复发率分别为2.9%(95% CI:1.8-4.6)和11.4%(95% CI:8.7-14.8)。
  • D-二聚体>1900 ng/mL组1年和5年累积复发率分别为5.0%(95% CI:4.0-6.1)和18.3%(95% CI:16.2-20.6)。
  • 无诱因静脉血栓栓塞症患者中,≤1900 ng/mL组5年累积复发率为14.3%(95% CI:10.3-19.7),>1900 ng/mL组为20.2%(95% CI:17.3-23.5)。

临床怎么用

  • 作者认为诊断时测得的D-二聚体水平或可用于识别复发风险低的静脉血栓栓塞症患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venous thromboembolism (VTE) is a frequent disease with a high risk of recurrence. It has been suggested that the D-dimer level at the time of VTE diagnosis can be used to identify patients at a low risk of recurrence. OBJECTIVES: We aimed to investigate the impact of D-dimer levels measured at the time of VTE diagnosis on the risk of recurrence in a large cohort of patients with a first-time VTE. METHODS: The study included 2585 patients with first symptomatic non-cancer-associated VTE from the Venous Thrombosis Registry in Østfold Hospital (TROLL) (2005-2020). All recurrent events during the follow-up were recorded, and cumulative incidences of recurrence were estimated according to D-dimer levels of ≤1900 ng/mL (≤25th percentile) and >1900 ng/mL. RESULTS: During a median follow-up of 3.3 years, 395 patients experienced a recurrent VTE. The 1- and 5-year cumulative incidences of recurrence were 2.9% (95% CI: 1.8-4.6) and 11.4% (95% CI: 8.7-14.8), respectively, in those with a D-dimer concentration of ≤1900 ng/mL and 5.0% (95% CI, 4.0-6.1) and 18.3% (95% CI: 16.2-20.6), respectively, in those with a D-dimer concentration of >1900 ng/mL, respectively. In patients with unprovoked VTE, the 5-year cumulative incidence was 14.3% (95% CI: 10.3-19.7) in the ≤1900-ng/mL category, and 20.2% (95% CI: 17.3-23.5) in the >1900-ng/mL category. CONCLUSIONS: D-dimer levels within the lowest quartile, measured at the time of VTE diagnosis, were associated with lower recurrence risk. Our findings imply that D-dimer levels measured at the time of diagnosis may be used to identify patients with VTE at a low risk of recurrent VTE.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Rinde FB, Jørgensen CT, Pettersen HH, et al. Low D-dimer levels at diagnosis of venous thromboembolism are associated with reduced risk of recurrence: data from the TROLL registry. J Thromb Haemost. 2023. PMID: 37004791. doi:10.1016/j.jtha.2023.03.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。